�����ƽ��

Obtaining high yields of viable engineered T cells for cell therapy research and immunotherapy development can be challenging. Lengthy and inefficient processes for cell isolation, cell culture, and gene transfer can cause delays and prevent scientists from reaching their goals. Watch as Drs. Sneha Balani and Angela Zhang discuss best practices and innovative technologies for T cell therapy research.

This webinar describes steps and considerations involved in translating research to the clinic.

Intracellular delivery of molecules is a key step in biological research, but traditional transfection methods are often limited in their ability to efficiently deliver macromolecules across diverse cell types without altering cell phenotype and function. <br><br>Watch this on-demand webinar—originally presented as a workshop at AAI 2025—to learn how the CellPore™ Transfection System addresses these limitations by using mechanoporation to create transient membrane pores, enabling direct cytosolic delivery with high efficiency and cell viability.

A modular framework for classifying T cells by lineage, function, migration, differentiation, and antigen context.

On this episode of the Immunology Podcast, Drs. Carl June and Philipp Rommel discuss their research in lymphocyte biology, with a major translational focus on ex vivo T cell engineering for cancer and HIV cell-based therapies.

This free Nature Protocols Wallchart summarizes the processes involved in producing CAR T cells for therapy.

.